MedWatch

Danish CRO reaches milestone in Sanofi deal

Denmark-based CRO Gubra has reached the first milestone in its research collaboration with the French drug giant Sanofi. More research deals could be on the way.

Foto: Sanofi

The Danish contract research organization Gubra has hit the first milestone in a research partnership the company struck with French giant Sanofi last year.

“It gives you a good feeling. This was the first major strategic partnership for us, so it was important for us to show that our project plan was realistic, that we reach the goals we set up, and that we reach them on time, as outlined in the contract,” Gubra's science chief, Jacob Jelsing, tells MedWatch.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier